Fraunhofer Institut für Angewandte Festkörperphysik IAF
Ergebnis der Suchanfrage nach Saarland
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 2mehr
Technische Universität München
A disease trigger for pancreatitis has been identified
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36036/ High resolution images: https://mediatum.ub.tum.de/1545776 NEWS RELEASE A Calcium channel is involved in the development of pancreatitis A disease trigger for pancreatitis has been identified One factor ...
mehrPM: Fast 600.000 Kinderbriefe haben Christkind, Weihnachtsmann und Nikolaus 2019 beantwortet
mehrTechnische Universität München
From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35822/ High resolution images: https://mediatum.ub.tum.de/1524870 NEWS RELEASE From cancer medication ...
mehrJust innovative: the Hager Group Annual Report 2011
mehrVDA - Verband der Automobilindustrie e.V.
IAA opens with 1,012 exhibitors and 183 world premieres - many models already "in motion" / Wissmann: Curtain up on the world's most important trade fair for mobility!
Frankfurt am Main/Berlin (ots) - "As the world's most important trade fair for mobility, the IAA offers a unique programme including 183 world premieres. The automotive manufacturers alone are presenting 89 world premieres. Over half of them, 45 in fact, are from German group brands. And the suppliers have 94 world ...
mehrEANS-Adhoc: SMT Scharf AG restructures subsidiary in Germany´s Saarland region
Further inquiry note: Investor Relations cometis AG Susanne Gremmler Tel: +49(0)611 - 205855-23 Fax: +49(0)611 - 205855-66 e-mail: gremmler@cometis.de issuer: SMT Scharf AG Römerstr. 104 D-59075 Hamm phone: +49(0)2381-960212 FAX: +49(0)2381-960311 sector: Machine Manufacturing ISIN: DE0005751986 indexes: stockmarkets: regulated dealing/prime standard: Frankfurt, ...
mehreuro adhoc: SMT Scharf AG / Financial Figures/Balance Sheet / SMT Scharf AG publishes Q3 2008 figures
Further inquiry note: Contact Investor relations cometis AG Susanne Gremmler Phone: +49(0)611 - 205855-23 Fax: +49(0)611 - 205855-66 E-mail: gremmler@cometis.de Branche: Machine Manufacturing ISIN: DE0005751986 WKN: 575198 Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade ...
mehrSMT Scharf AG publishes H1 2008 figures
Further inquiry note: Investor Relations cometis AG Susanne Gremmler Tel.: +49(0)611 - 205855-23 Fax: +49(0)611 - 205855-66 e-mail: gremmler@cometis.de Branche: Machine Manufacturing ISIN: DE0005751986 WKN: 575198 Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse München / free trade ...
mehrSMT Scharf AG acquires South African supplier of mining equipment Sareco Engineering CC
Further inquiry note: Contact Investor Relations cometis AG Henryk Deter Tel.: +49(0)611 - 205855-13 Fax: +49(0)611 - 205855-66 e-mail: deter@cometis.de Branche: Machine Manufacturing ISIN: DE0005751986 WKN: 575198 Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse München / free trade ...
mehrSMT Scharf AG publishes Q1 figures 2008
Further inquiry note: Contact Investor Relations cometis AG Henryk Deter Tel.: +49(0)611 - 205855-13 Fax: +49(0)611 - 205855-66 e-mail: deter@cometis.de Branche: Machine Manufacturing ISIN: DE0005751986 WKN: 575198 Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse München / free trade ...
mehrLandmark Trial ONTARGET(R) Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population. From ONTARGET(R) it May be Concluded That Telmisartan can Prevent Every 5th Serious Cardiovascular Event
Ingelheim, Germany (ots/PRNewswire) - - Results of 25,620 Patient Study ONTARGET(R) (ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial) Presented Today at the 57th Annual Scientific Session of the American College of Cardiology(1) - For Non-US Healthcare Media The results of the ...
mehr